← FDA DRUG APPROVALS

FDA ANDA · ANDA075500

SOTALOL HYDROCHLORIDE

Sponsor: AIPING PHARM INC

APPLICATION
ANDA075500
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-27
LATEST ACTION
2021-02-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

SORINEPrescription
SOTALOL HYDROCHLORIDE 80MG · TABLET · ORAL
SORINEPrescription
SOTALOL HYDROCHLORIDE 120MG · TABLET · ORAL
SORINEPrescription
SOTALOL HYDROCHLORIDE 160MG · TABLET · ORAL
SORINEPrescription
SOTALOL HYDROCHLORIDE 240MG · TABLET · ORAL

Approval history

2021-02-04Labeling · Supplement 17 · standardAP
2015-03-02Labeling · Supplement 14AP
2015-03-02Labeling · Supplement 15AP
2003-05-13Labeling · Supplement 2AP
2002-12-19Manufacturing (CMC) · Supplement 1AP
2001-04-27OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →